Irina Alimova
- Cancer Research top 5%
- Aging top 5%
- Oncology top 5%
- Cancer-related Molecular Pathways 5
- Molecular Biology top 5%
- Chromatin Remodeling and Cancer 9
- Epigenetics and DNA Methylation 5
- Protein Degradation and Inhibitors 5
- Genetics top 5%
- Glioma Diagnosis and Treatment 5
-
- Circadian rhythm and melatonin 6
-
- Cancer Mechanisms and Therapy 5
-
- Microtubule and mitosis dynamics 5
- Co-authors
- Zeying FanBolin LiuStuart E. LindAnn D. ThorSusan M. EdgertonSujatha VenkataramanRajeev VibhakarNicholas K. Foreman
- Cited by
- Cancer ResearchAgingOncology
- Partner nations
- United StatesRussiaGermany
In The Last Decade
Irina Alimova
34 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 466
- Aging 47
- Oncology 630
- Molecular Biology 1.5k
- Genetics 199
Countries citing papers authored by Irina Alimova
This map shows the geographic impact of Irina Alimova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina Alimova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina Alimova more than expected).
Fields of papers citing papers by Irina Alimova
This network shows the impact of papers produced by Irina Alimova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina Alimova. The network helps show where Irina Alimova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Irina Alimova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2016 | 33 | |
| 4 | 2014 | 57 | |
| 5 | 2012 | 67 | |
| 6 | 2012 | 94 | |
| 7 | 2012 | 50 | |
| 8 | 2011 | 9 | |
| 9 | 2009 | 430 | |
| 10 | 2009 | 337 | |
| 11 | 2003 | 7 | |
| 12 | 2003 | 15 | |
| 13 | 2003 | 16 | |
| 14 | 2003 | 7 | |
| 15 | 2003 | 3 | |
| 16 | 2002 | 27 | |
| 17 | 2002 | 56 | |
| 18 | 2002 | 4 | |
| 19 | 2002 | 4 | |
| 20 | The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. | 2001 | 32 |
About Irina Alimova
Irina Alimova is a scholar working on Endocrine and Autonomic Systems, Aging and Genetics, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chromatin Remodeling and Cancer (9 papers), Circadian rhythm and melatonin (6 papers), Cancer Mechanisms and Therapy (5 papers), Glioma Diagnosis and Treatment (5 papers), Epigenetics and DNA Methylation (5 papers), Microtubule and mitosis dynamics (5 papers), Protein Degradation and Inhibitors (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (466 citations), Aging (47 citations) and Oncology (630 citations). Irina Alimova has collaborated with scholars based in United States, Russia and Germany. Frequent co-authors include Zeying Fan, Bolin Liu, Stuart E. Lind, Ann D. Thor, Susan M. Edgerton, Sujatha Venkataraman, Rajeev Vibhakar, Nicholas K. Foreman, Peter S. Harris and Thomas E. Dillon. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.